Rankings
▼
Calendar
VRDN Q3 2016 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VRDN
Viridian Therapeutics, Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$889,000
Gross Profit
$290,000
32.6% margin
Operating Income
-$2M
-204.3% margin
Net Income
-$2M
-206.9% margin
EPS (Diluted)
$-2.56
QoQ Revenue Growth
+1.7%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$93,000
Balance Sheet
Total Assets
$8M
Total Liabilities
$3M
Stockholders' Equity
$5M
Cash & Equivalents
$5M
← FY 2016
All Quarters
Q4 2016 →
